Every year, we invite a number of plenary speakers who are experts in their respective fields. Their talks complement the Symposium sessions by providing a coherent overview on a variety of topics across the ALS/MND research and clinical management spectrum. Click on the images below to find out more about the plenary speakers who will be presenting at the Virtual 33rd International Symposium on ALS/MND. Please note, sessions are provisional so may be subject to change.
DAY 1 - TUESDAY 6 DECEMBER 2022
SESSION 1 - OPENING SESSION
The Stephen Hawking Memorial Lecture
Dr Fred Gage
The Salk Institute for Biological Studies, USA
DAY 2 - WEDNESDAY 7 DECEMBER 2022
SESSION 3 - METABOLISM AND NUTRITION
Prof Shyuan Ngo
The University of Queensland, Australia
SESSION 4 - CELL-BASED MODELS
Dr Kasper Roet
QurAlis, USA
SESSION 5 - DISEASE PRESENTATION AND RISK
Prof George Davey-Smith
University of Bristol, UK
Dr Carmela Tartaglia
Univeristy of Toronto, Canada
Dr Michael Benatar
Univeristy of Miami, USA
DAY 3 - THURSDAY 8 DECEMBER 2022
SESSION 6 - CELL BIOLOGY AND PATHOLOGY
Prof Janine Kirby
University of Sheffield, UK
SESSION 7 - RNA AND PROTEIN PROCESSING
Prof Heather Durham
Montreal Neurological Institute, McGill University
Prof Eran Hornstein
Weizmann Institute of Science, Israel
DAY 4 - FRIDAY 9 DECEMBER 2022
SESSION 8 - NEUROINFLAMMATION
Dr Jasna Kriz
Université Laval, Canada
Dr Stanley Appel
Houston Methodist Research Institute, USA
SESSION 9 - TRIAL DESIGN AND CLINICAL ENDPOINTS
Dr Ruben van Eijk
University Medical Center Utrecht, Netherlands
Dr Toby Ferguson
Biogen, Boston, USA
Stephanie Fradette
Biogen, Boston, USA
SESSION 10 - CLOSING SESSION
Dr Leigh Hochberg
Brown University, USA